The immune system and the hypothalamic-pituitary-adrenal axis are linked by several mechanisms. Intracellular glucocorticoid receptors represent one important connection. The aim of this study was to examine the coherence between the number of glucocorticoid receptors, activation of the hypothalamic-pituitary-adrenal axis, inflammatory cytokine levels and the severity of illness in critically ill patients.
In a prospective study, blood was collected from 20 healthy members of the hospital staff (control group) and 50 ventilated patients (sample group) within the first 24 hours after intubation and within three days of extubation. 5H-dexamethasone-binding assay was used to assess cytoplasmatic free glucocorticoid receptors levels. ACTH, cortisol, IL-6 and TNFα. levels were measured by ELISA.
In the sample group, specific binding of 5H-dexamethasone was significantly decreased compared to the control group. Glucocorticoid receptor levels tended to be lower in more severely ill patients. Plasma cortisol and ACTH levels were significantly different from the control group after extubation but not at intubation.
Severe illness is associated with rapid down-regulation of 5H-dexamethasone binding. This decrease occurs before elevation of plasma cortisol. Therefore, down-regulation of cortisol binding may be directly associated with the stress response and not due to feedback regulation following increase in plasma cortisol levels.
MarikP.E.Mechanisms and clinical consequences of critical illness associated adrenal insufficiency.Curr Opin Crit Care2007; 13: 363–369.
2.
PrigentH., MaximeV., AnnaneD.Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids.Crit Care2004; 8: 243–252.
3.
SpanL.F., HermusA.R., BartelinkA.K., HoitsmaA.J., GimbrereJ.S., SmalsA.G.Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients.Intensive Care Med1992; 18: 93–96.
4.
AnnaneD., BellissantE., BollaertP.E., BriegelJ., KehD., KupferY.Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis.BMJ2004; 329: 480.
5.
ReinckeM., AllolioB., WurthG., WinkelmannW.The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.J Clin Endocrinol Metab1993; 77: 151–156.
6.
DimopoulouI., AlevizopoulouP., DafniU., OrfanosS., LivaditiO., TzanelaM.Pituitary-adrenal responses to human corticotropin-releasing hormone in critically ill patients.Intensive Care Med2007; 33: 454–459.
7.
SilvermanM.N., PearceB.D., BironC.A., MillerA.H.Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.Viral Immunol2005; 18: 41–78.
8.
MaurerM., TrajanoskiZ., FreyG., HiroiN., GalonJ., WillenbergH.S.Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells.Horm Metab Res2001; 33: 691–695.
9.
LiuL.Y., SunB., TianY., LuB.Z., WangJ.Changes of pulmonary glucocorticoid receptor and phospholipase A2 in sheep with acute lung injury after high dose endotoxin infusion.Am Rev Respir Dis1993; 148: 878–881.
10.
KnausW.A., ZimmermanJ.E., WagnerD.P., DraperE.A., LawrenceD.E.APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.Crit Care Med1981; 9: 591–597.
11.
Le GallJ.R., LemeshowS., SaulnierF.A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.JAMA1993; 270: 2957–2963.
12.
MolijnG.J., KoperJ.W., van UffelenC.J., de JongF.H., BrinkmannA.O., BruiningH.A.Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock.Clin Endocrinol (Oxf)1995; 43: 197–203.
13.
Lipiner-FriedmanD., SprungC.L., LaterreP.F., WeissY., GoodmanS.V., VogeserM.Adrenal function in sepsis: the retrospective Corticus cohort study.Crit Care Med2007; 35: 1012–1018.
14.
BriegelJ., SchellingG., HallerM., MrazW., ForstH., PeterK.A comparison of the adrenocortical response during septic shock and after complete recovery.Intensive Care Med1996; 22: 894–899.
15.
GwosdowA.R., KumarM.S., BodeH.H.Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis.Am J Physiol1990; 258: E65–70.
16.
ChrousosG.P.The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture.Ann N Y Acad Sci2000; 917: 38–67.
17.
JuddA.M., CallG.B., BarneyM., McIlmoilC.J., BallsA.G., AdamsA.Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion.Ann N Y Acad Sci2000; 917: 628–637.
18.
SilvermanM.N., MillerA.H., BironC.A., PearceB.D.Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection.Endocrinology2004; 145: 3580–3589.
19.
DimopoulouI., IliasI., RoussouP., GavalaA., MalefakiA., MilouE.Adrenal function in non-septic long-stay critically ill patients: evaluation with the low-dose (1 micro g) corticotropin stimulation test.Intensive Care Med2002; 28: 1168–1171.
NatarajanR., PloszajS., HortonR., NadlerJ.Tumor necrosis factor and interleukin-1 are potent inhibitors of angiotensin-II-induced aldosterone synthesis.Endocrinology1989; 125: 3084–3089.
22.
JaattelaM., CarpenO., StenmanU.H., SakselaE.Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-alpha.Mol Cell Endocrinol1990; 68: R31–36.
23.
CostasM., TrappT., PeredaM.P., SauerJ., RupprechtR., NahmodV.E.Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.J Clin Invest1996; 98: 1409–1416.
24.
LiuD.H., SuY.P., ZhangW., LuS.F., RanX.Z., GaoJ.S.Changes in glucocorticoid and mineralocorticoid receptors of liver and kidney cytosols after pathologic stress and its regulation in rats.Crit Care Med2002; 30: 623–27.
25.
EbelingP., KoivistoV.A.Physiological importance of dehydroe-piandrosterone.Lancet1994; 343: 1479–1481.
26.
BeishuizenA., ThijsL.G.Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.J Endotoxin Res2003; 9: 3–24.
27.
LuppaP., MunkerR., NagelD., WeberM., EngelhardtD.Serum androgens in intensive-care patients: correlations with clinical findings.Clin Endocrinol (Oxf)1991; 34: 305–310.
28.
IliasI., StamoulisK., ArmaganidisA., LyberopoulosP., TzanelaM., OrfanosS.Contribution of endocrine parameters in predicting outcome of multiple trauma patients in an intensive care unit.Hormones (Athens)2007; 6: 218–226.
29.
DimopoulouI., StamoulisK., IliasI., TzanelaM., LyberopoulosP., OrfanosS.A prospective study on adrenal cortex responses and outcome prediction in acute critical illness: results from a large cohort of 203 mixed ICU patients.Intensive Care Med2007; 33: 2116–2121.
30.
StraubR.H., KonecnaL., HrachS., RotheG., KreutzM., ScholmerichJ.Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence.J Clin Endocrinol Metab1998; 83: 2012–2017.
